MedPath

M. Arkin (1999) Ltd.

🇮🇱Israel
Ownership
Subsidiary
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Phase 1:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (100.0%)

Clinical Study to Evaluate Tolerability and Safety of ARK-E021 Foam and to Monitor Clinical Effect in Acne Vulgaris Patients

Phase 1
Completed
Conditions
Acne Vulgaris
Interventions
Drug: Placebo
Drug: ARK-E021 5%
Drug: ARK-E021 10%
First Posted Date
2011-12-16
Last Posted Date
2013-12-03
Lead Sponsor
M. Arkin 1999 Ltd.
Target Recruit Count
157
Registration Number
NCT01494285
Locations
🇮🇱

HaEmek Medical Center, Afula, Israel

🇮🇱

Meir Medical Center, Kfar Saba, Israel

🇮🇱

Souraski Medical Center, Tel Aviv, Israel

News

No news found
© Copyright 2025. All Rights Reserved by MedPath